BSE Live
Oct 16, 16:01Prev. Close
1140.00
Open Price
1139.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 16, 15:43Prev. Close
1132.50
Open Price
1135.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1134.00 (3)
Profit & Loss account of SMS Lifesciences India (in Rs. Cr.) | Mar 20 | Mar 19 | |
12 mths | 12 mths | ||
INCOME | |||
Revenue From Operations [Gross] | 286.38 | 411.79 | |
Less: Excise/Sevice Tax/Other Levies | 29.75 | 38.57 | |
Revenue From Operations [Net] | 256.63 | 373.22 | |
Total Operating Revenues | 260.78 | 377.85 | |
Other Income | 2.28 | 2.51 | |
Total Revenue | 263.06 | 380.37 | |
EXPENSES | |||
Cost Of Materials Consumed | 147.04 | 268.79 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | |
Operating And Direct Expenses | 40.30 | 50.54 | |
Changes In Inventories Of FGWIP And Stock In Trade | 10.84 | -12.92 | |
Employee Benefit Expenses | 26.56 | 23.11 | |
Finance Costs | 5.14 | 5.51 | |
Depreciation And Amortisation Expenses | 7.86 | 6.38 | |
Other Expenses | 10.65 | 13.56 | |
Total Expenses | 248.39 | 354.98 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 14.67 | 25.39 | |
Exceptional Items | 0.00 | 0.00 | |
Profit/Loss Before Tax | 14.67 | 25.39 | |
Tax Expenses-Continued Operations | |||
Current Tax | 3.65 | 6.70 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | |
Deferred Tax | 0.79 | 0.92 | |
Other Direct Taxes | 0.00 | 0.00 | |
Total Tax Expenses | 4.48 | 7.54 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 10.18 | 17.85 | |
Profit/Loss From Continuing Operations | 10.18 | 17.85 | |
Profit/Loss For The Period | 10.18 | 17.85 | |
Minority Interest | 0.00 | 0.00 | |
Consolidated Profit/Loss After MI And Associates | 10.18 | 17.85 | |
OTHER ADDITIONAL INFORMATION | |||
EARNINGS PER SHARE | |||
Basic EPS (Rs.) | 34.00 | 59.00 | |
Diluted EPS (Rs.) | 34.00 | 59.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | |||
Equity Share Dividend | 0.00 | 1.18 | |
Tax On Dividend | 0.00 | 0.24 |
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017